Section Reviews: Biologicals & Immunologicals: Pharmacological attenuation of chemotherapy-induced oral mucositis
- 1 September 1996
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 5 (9) , 1155-1162
- https://doi.org/10.1517/13543784.5.9.1155
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Effects of IL‐11 on the growth of intestinal epithelial cells in vitroCell Proliferation, 1995
- Oral capsaicin provides temporary relief for oral mucositis pain secondary to chemotherapy/radiation therapyJournal of Pain and Symptom Management, 1995
- Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.The Journal of Experimental Medicine, 1994
- Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) with other antioxidantsHead & Neck, 1994
- The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Cancer Therapy and Oral MucositisDrug Safety, 1993
- Local benefit of prostaglandin E2 in radiochemotherapy-induced oral mucositisBritish Journal of Oral and Maxillofacial Surgery, 1990
- Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositisThe Journal of Pediatrics, 1988
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the UrotheliumNew England Journal of Medicine, 1988